Patent – Infringement. In a patents claim concerning tadalafil, a product sold for male erectile dysfunction, the Patents Court held that at least one claim of patent EP (UK) 1,173,181 (181), relating to dosing, was valid and infringed. With respect to EP (UK) 1,200,092 (092), relating to drug formation, all of its claims were invalid.